MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
SAVA - Cassava Sciences Inc
$41.82
-1.25(-2.90%)8:00:01 PM 9/30/2022
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for nervous system disorders. Its lead therapeutic product candidate is PTI-125, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • MACD is crossing MACD signal line at 0.4. MACD crossing signal line is bullish signal.
Stock Statistics
MarketCap1.7B
PE Ratio
PEG Ratio5.0
P/B11.3
P/S (ttm)
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %10%
Held by Institutions %28%
1 Day Vol Adjusted Return-0.2
1 Month Vol Adjusted Return5.3
3 Month Vol Adjusted Return6.5
6 Month Vol Adjusted Return1.6
20 Days SMA Price ZScore0.8
50 Days SMA Price ZScore1.6
12 -26 Days PPO13.5
1 Month Average Short Volume Ratio51.8
1 Day Volume Change ZScore-0.6
1 Month Daily Vol11.9
Related Topics
Peers

Stock news